-
NPS Clinical Update – Designer Opioids and Benzodiazepines August 2020
NPS Clinical Update – Designer Opioids and Benzodiazepines August 2020 …
-
Synthetic Cannabinoids and Synthetic Stimulants July 2020
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled…
-
Expansion of Oral Fluid Testing of Behavioral Health Drugs
Aegis’ oral fluid testing menu has been expanded to allow providers the option to test for many additional medications and/or illicit drugs. The enhancement…
-
Review of New InterAct Rx Analyte Positivity
In 2015, Aegis Sciences Corporation began to seek out a way to expand the clinical information that could be provided through definitive testing. With…
-
Broaden your Understanding: Benefits of the InterACT Rx™ Expansion
In 2015, Aegis Sciences Corporation began to seek out a way to expand the clinical information that could be provided through definitive testing. With…
-
Introduction to Pharmacogenetic (PGx) for Pain Management
Aegis offers pharmacogenetic testing focusing on medication/gene pairs that are supported by clinical guidelines, FDA-approved labeling, or clinical studies…
-
Introduction to PGx for Behavioral Health
Aegis offers pharmacogenetic testing, with a majority of the available tests focusing on medications prescribed in behavioral health. The testing menu…
